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Introduction: The aim of this study was to investigate the clinical outcomes between 2 groups of elderly
rectal cancer patients according to the time duration after which their diverting stoma can be reversed.
Methods: We recruited 124 patients who were 65 years old and had undergone diverting stoma after
rectal cancer surgery. In Group 1, the reversal of the stoma was predominantly performed after the sixth
adjuvant chemotherapy. In Group 2, the reversal was predominantly performed after the third adjuvant
chemotherapy. Results: The mean duration for which patients had a stoma was 28.6 ± 9.9 weeks in
Group 1 and 17.1 ± 7.4 weeks in Group 2. The interval between stoma formation and stoma formation-
related complications was slightly longer in Group 1 than in Group 2 (13.5 ± 9.7 vs. 8.0 ± 4.9 weeks,
p ¼ 0.075). There were 16 stoma-related complications in Group 1 (23.2%) and 10 in Group 2 (18.2%)
(p ¼ 0.516). There were 6 stoma closure-related complications in Group 1 (8.8%) and 6 in Group 2 (10.9%)
(p ¼ 0.766). Discussion: This study shows that stoma closure during adjuvant chemotherapy is no more
harmful than stoma closure after termination of adjuvant chemotherapy. Conclusion: It may be possible
to limit the duration of diverting stoma following rectal cancer surgery, even if patients are elderly and
undergoing adjuvant chemotherapy.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
According to Heald et al. [1], low anterior resection with total
mesorectal excision (TME) is the operation of choice for rectal
cancer and is widely adopted by colorectal surgeons. However,
there are concerns regarding low anastomosis leakage after low
anterior resection with TME. Therefore, surgeons commonly use a
diverting stoma after rectal surgery, primarily to protect the.
by Elsevier Ltd. All rights reservedanastomosis and prevent pelvic sepsis. Several studies have shown
that a covering stoma reduced the number of leaks requiring sur-
gery [2e4]. One study proposed that the absence of a diverting
stoma was a risk factor for symptomatic anastomotic leakage in
patients undergoing TME for rectal cancer [4]. However, it is well
known that diverting stomas have various adverse effects on
quality of life and cause major psychological handicap and physical
stress [5]. Closure of the diverting stoma might therefore reduce
both stoma-related morbidity and patient discomfort.
Although the optimal timing for closure of a diverting stoma is
not known, clinicians usually advise their patients that their
diverting stoma will be closed within 6e12 weeks of their initial.
Table 1
Comparison of clinical parameters between 2 groups.
Group 1 (n ¼ 69) Group 2 (n ¼ 55) p-Value
Sex
Male 47 (68.1%) 33 (60.0%) 0.450
Female 22 (31.9%) 22 (40.0%)
Age 74.1 ± 5.5 72.7 ± 4.9 0.156
Duration of diverting
stoma (weeks)




13.5 ± 9.7 8.0 ± 4.9 0.075
Stage (by ﬁnal pathologic
ﬁndings)a
0 or Tis 12 (17.4%) 6 (10.9%) 0.269
1 19 (27.5%) 11 (7.3%)
2 17 (24.6%) 18 (32.7%)
3 19 (27.5%) 16 (29.1%)
4 2 (2.9%) 4 (7.3%)
Surgical approach
Laparoscopic 67 (97.1%) 48 (87.3%) 0.076
Open 2 (2.9%) 7 (12.7%)
Neoadjuvant CRTxb
Yes 59 (85.5%) 45 (81.8%) 0.629
No 10 (14.5%) 10 (18.2%)
Type of stoma
Loop ileostomy 62 (89.9%) 52 (94.5%) 0.510
T-loop colostomy 7 (10.1%) 3 (5.5%)
Adjuvant chemotherapy
before the closure of
stoma (cycles)
5.1 ± 1.8 2.1 ± 1.6 <0.0001
Stoma formation-related
complication
Yes 16 (23.2%) 10 (18.2%) 0.516
No 53 (76.8%) 45 (81.8%)
Stoma closure-related
complication
Yes 6 (8.8%) 6 (10.9%) 0.766
No 62 (91.2%) 49 (89.1%)
a All patients with stage I or lesser rectal cancer had received neoadjuvant che-
moradiation before radical surgery. Stages described in manuscript were their ﬁnal
pathologic stages. Their initial clinical stages before radical surgery were stage II or
higher.
b CRTx: chemoradiation therapy.
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the initial resection, softening of intra-abdominal adhesions, and
resolution of inﬂammation and edema within the abdomen and
around the stomal oriﬁce [8]. However, the timing of diverting
stoma closure is variable and depends on a variety of factors such as
age, the need for adjuvant therapy for the underlying cancer,
stoma-related complications, and the type of stoma [9].
In this study, we compared the clinical outcomes between 2
groups of elderly rectal cancer patients according to the time
duration after which their diverting stomas can be reversed. We
aimed to identify the optimal time for reversal of diverting stomas
in rectal cancer patients who had undergone sphincter-saving
procedures (SSP) with TME and diverting stoma.
2. Patients and methods
We recruited 220 patients who underwent SSP with diverting
stoma after rectal cancer surgery in St. Vincent's Hospital, The
Catholic University of Korea, between June 2004 and March 2011. A
total of 91 patients under the age of 65 were excluded to reduce any
potential age-related bias. Furthermore, 6 of 130 patients whowere
65 years or older were excluded from this study because they did
not undergo the diverting stoma closure procedure. Therefore, 124
remaining patients who underwent diverting stoma closure pro-
cedures were included in this study. All 124 patients underwent
adjuvant chemotherapy after SSP with TME. After obtaining review
board approval from our institute (VC12RISI0017), demographics
and clinical information of the 124 patients who underwent SSP
with TME and diverting stoma for rectal cancer was collated. We
reviewed the medical records of all 124 patients retrospectively.
We divided our patients into 2 groups: the stoma closure
operation was performed in Group 1 between June 2004 and May
2009, and in Group 2, between June 2009 and April 2011. The
groupings largely reﬂected stoma closure operations performed
predominantly after the end of the sixth adjuvant chemotherapy
(5-FU and leucovorin chemotherapy) in Group 1 and third adjuvant
chemotherapy in Group 2. In Group 2, patients had undergone
remained adjuvant chemotherapy after stoma closure operation
until sixth adjuvant chemotherapy. Not all the patients in group 1
ﬁnished 6 cycles of adjuvant chemotherapy. Some of them had
diverting stoma related complications, which brought the stoma
closure earlier than planned then continued the last of chemo-
therapy after the closure. However, we marked them as Group 1
since the basic principle of stoma closure timing of patients in
Group 1 was after ﬁnishing all the 6 cycles of chemotherapy. With
this grouping, 69 patients were assigned to Group 1 and 55 patients
to Group 2.
We classiﬁed diverting stoma formation-related complication
into 3 categories: acute renal failure caused by high output of stoma
content (high output ARF), adhesive ileus, and complications
requiring emergency surgery. We did not experience complications
other than those three, like skin problem, stoma retraction, wound
infection, dehiscence, abdominal abscess, colonic pseudo obstruc-
tion, Clostridium difﬁcile colitis, etc. in our series of study. We
deﬁned high output ARF as the combination of stoma content
output of more than 1000 ml, dehydration, and elevated blood urea
nitrogen and creatinine on laboratory investigation. Adhesive ileus
indicated small bowel adhesion to the stoma site. Complications
requiring emergency surgery included parastomal hernia with
proximal obstruction, stoma site perforation, and prolapsed stoma
with strangulated bowel. If adhesive ileus occurred within 30 days
of stoma closure surgery, this was included into stoma closure-
related complications.
All patients who experienced diverting stoma-related compli-
cations had received treatment as inpatients. Patients with highoutput ARF were treated by conservative care until normal renal
function was regained. Thereafter, they underwent a diverting
stoma closure operation electively after the full evaluation of the
low anastomosis site. The full evaluation of the low anastomosis
site included digital rectal examination, ﬂexible colonoﬁberscopy
or sigmoidoscopy, and abdominopelvic CT. Patients with adhesive
ileus were treated by conservative care until normal bowel function
was restored. Then, they were treated as per the protocol for high
output ARF. None of the patients with high output ARF or adhesive
ileus required emergency surgery. Patients who suffered from
parastomal hernia with proximal obstruction or prolapsed stoma
with strangulated bowel were treated by emergency stoma closure
operation after evaluation of the low anastomosis site by digital
rectal examination and abdominopelvic CT. One stoma site perfo-
ration was treated with an emergency refashioning procedure fol-
lowed by elective stoma closure at a later date.
The following parameters were compared between the groups:
sex, age, whether or not the patient received neoadjuvant che-
moradiation therapy (nCRTx), operative method for rectal cancer
surgery (laparoscopy or open), the reason why diverting stoma
was required (routine procedure or low anastomosis leakage),
type of diverting stoma (loop ileostomy or loop colostomy), and
the duration for which the diverting stoma was maintained be-







(n ¼ 16, 23.2%)
Group 2
(n ¼ 10, 18.2%)
p-Value
High output ARFa 3 (4.3%) 5 (9.1%) 0.032
Adhesive ileus 9 (13.0%) 0
Emergency operation
required
4 (5.9%) 5 (9.1%)
Parastomal hernia 3 1





(n ¼ 6, 8.7%)
Group 2
(n ¼ 6, 10.9%)
p-Value




Incisional Hernia 1 (1.5%) 0
a ARF: acute renal failure.
b This patient suffered from closure site (ileo-ileal anastomosis) leakage following
wound infection. This leakage developed an enterocutaneous ﬁstula without peri-
tonitis. The patient responded well to conservative care, including nothing per oral
with parenteral nutritional support and antibiotic therapy.
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categorical variables were used to compare the clinicopathological
features between 2 groups. Continuous variables are expressed as
the mean ± standard error, whereas statistical signiﬁcance is
accepted at p < 0.05. The applied statistical software used was
SPSS® 12.0 (SPSS Inc., Chicago, IL, USA).
3. Results
A total of 124 patients, including 80 men and 44 women, were
included in this study. The patients' age ranged from 65 to 92 years,
with a mean age of 73.5 ± 5.3 years. Overall leakage rate of low
colorectal or coloanal anastomosis after SSP with TME was 4.03%
(5/124). In total, 3 patients (4.3%, 3/69) in Group 1 and 2 patients
(3.6%, 2/55) in Group 2 experienced low colorectal or coloanal
anastomosis site leakage. Leakage that warranted pelvic sepsis or
reoperation did not occur.
The mean durations of diverting stomawere 28.6 ± 9.9 weeks in
Group 1 and 17.1 ± 7.4 weeks in Group 2 (p < 0.0001). The interval
between stoma formation and stoma formation-related complica-
tions was slightly higher in Group 1 than in Group 2 (13.5 ± 9.7 vs.
8.0 ± 4.9 weeks, p¼ 0.075). There were no signiﬁcant differences in
clinical parameters and stoma-related complications between the 2
groups (Table 1). When patients who underwent nCRTx in both
groups were compared, similar results were observed (Table 2).
The overall complication rates associated with diverting stoma
formation and diverting stoma closure were 20.9% and 10.8%,
respectively. Adhesive ileus was the most common stoma
formation-related complication in Group 1, whereas high outputTable 2
Comparison of clinical parameters between 2 groups who underwent neoadjuvant
concurrent chemoradiation therapy.
Group 1 (n ¼ 59) Group 2 (n ¼ 45) p-Value
Sex
Male 40 (67.8%) 27 (60.0%) 0.418
Female 19 (32.2%) 18 (40.0%)
Duration of diverting
stoma (weeks)




12.9 ± 9.9 7.9 ± 5.3 0.196
Stage (by ﬁnal pathologic
ﬁndings)a
0 or Tis 12 (20.3%) 6 (13.3%) 0.787
1 16 (27.1%) 11 (24.4%)
2 14 (23.7%) 15 (33.3%)
3 15 (25.4%) 11 (24.4%)
4 2 (3.4%) 2 (4.4%)
Surgical approach
Laparoscopic 58 (98.3%) 42 (93.3%) 0.313
Open 1 (1.7%) 3 (6.7%)
Type of stoma
Loop ileostomy 55 (93.2%) 43 (95.6%) 0.696
T-loop colostomy 4 (6.8%) 2 (4.4%)
Adjuvant chemotherapy
before the closure of
stoma (cycles)
5.1 ± 1.8 1.9 ± 1.5 <0.001
Stoma formation-related
complication
Yes 14 (23.7%) 9 (20.0%) 0.812
No 45 (76.3%) 36 (80.0%)
Stoma closure-related
complication
Yes 6 (10.3%) 5 (11.1%) 1.000
No 53 (89.7%) 40 (88.9%)
a All patients with stage I or lesser rectal cancer had received neoadjuvant che-
moradiation before radical surgery. Stages described in manuscript were their ﬁnal
pathologic stages. Their initial clinical stages before radical surgery were stage II or
higher.ARF was the most common complication in Group 2 (p ¼ 0.013).
Overall, 12 patients underwent stoma closure-related complica-
tions (Table 3). Of these, 10 patients experienced adhesive ileus
after stoma closure operation, and they were treated conserva-
tively. One patient developed an incisional hernia on the stoma
closure site 4 months post-surgery and was treated by hernior-
rhaphy. The remaining patient suffered from closure site (ileo-ileal
anastomosis) leakage following wound infection. This leakage
developed an enterocutaneous ﬁstula without peritonitis. The pa-
tient responded well to conservative care, including nothing per
oral with parenteral nutritional support and antibiotic therapy.
There were no complications associated with low colorectal or
coloanal anastomosis after the closure of stomas in both Group 1
and Group 2. There was no low colorectal or coloanal anastomosis
leakage after the closure of stomas.Fig. 1. Interval between stoma formation and each complication associated with stoma
formation. A dot line shows the mean durations of diverting stoma in Group 2. The
mean intervals between stoma formation and each stoma formation-related compli-
cations are 8.5 ± 6.3 weeks in high output ARF, 13.7 ± 10.5 weeks in adhesive ileus, and
11.7 ± 8.3 weeks in complications requiring emergency operation.
B.-H. Kye et al. / International Journal of Surgery 12 (2014) 1337e13411340Comparing the interval between stoma formation and each
complication associated with stoma formation in patients who
underwent stoma formation-related complication in both groups,
adhesive ileus, which had been observed in only Group 1, had been
occurred even in longer time than the mean stoma duration of
Group 2 (17.1 ± 7.4 weeks) (Fig. 1).
The 7 patients who suffered from stoma formation-related
complication (3 parastomal hernias, 2 prolapsed stomas, and 2
high output ARFs) underwent stoma closure operations within 10
weeks of stoma formation. None of these patients experienced
further complications after the stoma closures.
4. Discussion
Diverting stoma closure surgeries may be inﬂuenced by the time
needed to recover psychologically and physically from the initial
operation, especially when the patient is critically ill at the time of
the initial procedure. Most clinicians usually advise their patients
that their diverting stomas will be closed within 6e12 weeks of
their initial surgery [6,7]. However, multiple factors may lead to
delays in scheduled diverting stoma closures. Taylor et al. [10]
identiﬁed 4 principal factors that inﬂuenced the timing of divert-
ing stoma closure: 1) advanced age, 2) the need for further treat-
ment of underlying cancer, 3) stoma and surgical complications,
and 4) type of stoma. They demonstrated that advanced age
inﬂuenced delayed stoma closure and non-closure rate, post-
operative chemotherapy was associated with longer times to
closure of diverting stomas, patients who developed a post-
operative complication at initial surgery extended the time to
surgical closure of their diverting stoma, and loop ileostomy or
double-barrel ostomy was associated with higher closure rates.
However, because diverting stoma remains a major psychological
handicap and causes signiﬁcant physical stress, leading to an
adverse effect on quality of life, delaying closure of diverting stomas
may be problematic to patients. Recently, some reports demon-
strated that early closure of the diverting stoma was feasible in
patients who had an uneventful recovery after rectal resections
[7,11,12]. Early closure of the diverting stoma might therefore
reduce both stoma-related morbidity and patient discomfort.
The treatment options for stoma-related complications include
conservative care, refashioning of the diverting stoma, or closure of
the diverting stoma [13e15]. However, the safety of a low anasto-
mosis following stoma closure in patients who underwent SSP with
TME for rectal cancer is of particular concern. In this study, we
selected stoma closure surgery after careful examination with
digital rectal examination, abdominopelvic CT, and endoscopic
examination as a means of assessing low colorectal or coloanal
anastomosis. The 7 patients who suffered from stoma formation-
related complications (3 parastomal hernias, 2 prolapsed stomas,
and 2 high output ARFs) still underwent stoma closure surgery
within 10 weeks of stoma formation. None of these patients
experienced further complications after the closure of their stoma.
Although data was not shown, complication rates after stoma
closure in these 7 patients were not signiﬁcantly different from
those in patients who underwent stoma closure more than 10
weeks after initial surgery. Based on this result, we propose that
when a stoma formation-related complication develops, stoma
closure may be a viable treatment option, even during the early
postoperative period.
Kairaluoma et al. [16] found a signiﬁcantly higher non-closure
rate among patients over 70 years. They reported that 36% of pa-
tients aged 70 years or older underwent stoma closure. Although
this study was performed in the 1990s, advanced age is a known
factor affecting closure surgery. This was conﬁrmed by an addi-
tional recent study, which demonstrated that age greater than 70years was associatedwith a lower likelihood of closure surgery [17].
In the present study, patients who were 65 years or older were
enrolled to reduce age-related bias for closure surgery and because
the incidence of rectal cancer gradually increases in old age.
Approximately 95.4% (124/130) of our patients underwent stoma
closure. Only 6 diverting stomas (4.6%) were not closed because 3
patients did notwant any further treatment after initial surgery and
the other 3 patients had tumor progression including local tumor
recurrence. As current surgical techniques, including TME, for rectal
cancer and anesthesia have been developed and improved, most
colorectal surgeons are experienced in SSP and stoma reversal.
With the increasing incidence of rectal cancer in elderly patients,
treatment for the disease in this cohort of patients has beneﬁted
from remarkable technical developments. The results of our study
indicate that old age no longer inﬂuences the rate of diverting
stoma closures in elderly rectal cancer patients.
Patients with rectal cancer are increasingly being offered post-
operative adjuvant chemotherapy, which creates uncertainty about
the timing of stoma closure. It is not known whether adjuvant
therapy in patients with rectal cancer has an impact on the
morbidity of diverting stoma. Nor is it known whether the optimal
timing for closure of a temporary stoma in patients with rectal
cancer is before, during, or after adjuvant chemotherapy. Some
studies show a signiﬁcant delay in stoma closure in patients who
had received adjuvant chemotherapy [17,18]. This may be an as-
sociation or a direct result. Moreover, this may be inﬂuenced by the
stage of disease that deﬁnes the need for adjuvant therapy, or the
therapy itself, resulting in further delay of stoma closure. However,
many stoma-related complications are more commonly observed if
there is a prolonged wait before reversal [19]. Thalheimer et al. [20]
demonstrated that the fewest complications were seen in patients
who underwent ileostomy closure before the start of adjuvant
chemotherapy or radiochemotherapy (12.5%), followed by patients
undergoing closure after termination of (21.2%) or during adjuvant
therapy (42.9%). They suggested that the comparatively high
complication rates in the latter 2 groups could be the result of the
patients' poor general physical condition, with decreased wound-
healing capacity during and after termination of chemotherapy or
radiochemotherapy lasting up to 6 months. Lordan et al. [18]
advocate closing temporary stomas prior to starting adjuvant
therapy. They point out that postoperative therapy often does not
start for 2e3 weeks after an anterior resection; therefore, in many
patients, it would be possible to close their loop stoma ﬁrst. This
would avoid a long delay in closure after adjuvant therapy and the
complications associated with loop stomas. In a recent study which
had analyzed two groups divided by similar methods with our
study, authors demonstrated that closure during the course of
chemotherapy did not worsen the short-term outcome because
there was no difference between two groups with regard to length
of hospital stay, the rate of ileostomy closure complications and
mortality [21]. In the present study, although there was no statis-
tically signiﬁcant difference, stoma-related complication rates in
Group 1 (23.2%) were higher than those in Group 2 (18.2%)
(p ¼ 0.516). An adhesive ileus, which had been observed in only
Group 1, had developed even after 17.1 weeks, which was mean
duration of diverting stoma in Group 2. This study shows that
stoma closure during adjuvant chemotherapy is no more harmful
than stoma closure after termination of adjuvant chemotherapy. As
shown in Table 2, this result may be applied to patients who un-
dergo nCRTx.
Some studies, including 2 prospective trials, demonstrated that
early stoma closure within 2 weeks of initial surgery would be
feasible and safe for the majority of patients after colorectal or
coloanal anastomosis [11,12,18,20]. However, we did not attempt
early stoma closure even if a patient's recovery was uneventful. In
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coloanal anastomosis. In most rectal cancer patients who undergo
TME with colorectal or coloanal anastomosis, the so-called anterior
resection syndrome, which is characterized by defecatory
dysfunction such as frequent defecation, urgency, and incontinence
after SSP, especially with low anastomosis, would be problematic
[22e24]. This is even more of a concern in elderly patients, whose
sphincter functions would be poor. These disordered bowel func-
tions have a negative effect on the patient's quality of life and can
affect adjuvant chemotherapy compliance. In light of this, we have
chosen to undertake stoma closure surgeries after the third adju-
vant chemotherapy, to improve compliance and prepare patients
for changes in their bowel function. Moreover, it has beneﬁts such
as short term follow up and prompt care for disordered bowel
function to have stoma closure done during the adjuvant chemo-
therapy for the elderly patients.
Our study has limitations in that it was retrospective using the
records of patients and follow-up could not be performed for all
patients. It must be emphasized that this study did not assess the
effect of systemic illness such as nutritional status, hypertension or
diabetes in elderly patients and the number of patients was limited.5. Conclusion
In the event of stoma-related complications in elderly rectal
cancer patients, stoma closure surgery after identifying the safety of
low anastomosis may alleviate these complications. The duration
between formation and closure of diverting stoma following SSP
with TME may be shortened, even in elderly rectal cancer patients.
Moreover, it may be possible to shorten this interval even during
adjuvant chemotherapy. However, a prospective randomized trial is
required to support our conclusions.Ethical approval
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